BIOTEST BIOTECH(688767.SH)

Last Updated 00:00:00
longbridge loading
Company Encyclopedia
View More
name
BIOTEST BIOTECH
688767.SH
Hangzhou Biotest Biotech Co.,Ltd. engages in the research and development, manufacture, sale, and service of in vitro diagnostic assays and reagents, and instruments in China and internationally. The company offers medical test products for fertility health, cardiology, oncology, inflammation, biochemistry, and various infectious diseases. It also provides veterinary test kits; fluorescence immunoassay rapid test kits; and other rapid testing kits.
1.468 T
688767.SHMarket value -Rank by Market Cap -/-

Financial Score

19/05/2026 Update
C
BiotechnologyIndustry
Industry Ranking47/81
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreC
    • ROE1.27%D
    • Profit Margin6.74%B
    • Gross Margin47.56%B
  • Growth ScoreD
    • Revenue YoY-12.15%E
    • Net Profit YoY-78.13%E
    • Total Assets YoY-2.27%D
    • Net Assets YoY-2.47%D
  • Cash ScoreC
    • Cash Flow Margin200.92%B
    • OCF YoY-12.15%E
  • Operating ScoreD
    • Turnover0.18D
  • Debt ScoreA
    • Gearing Ratio4.90%A

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    AI TRENDS | Brain-Computer Interface Technology Set for Commercial Expansion by 2026

    CoinLive·
    SH
    688626
    +4.72%
    SZ
    159998
    +0.99%
    SZ
    002555
    +2.03%
    CoinLive·
    SH
    688626
    +4.72%
    SZ
    159998
    +0.99%
    SZ
    002555
    +2.03%

    Brain-computer interfaces are becoming a reality, with over 100 institutions researching 5 concept stocks this year

    36Kr·
    SZ
    300753
    +2.26%
    SZ
    301330
    +2.74%
    SH
    688626
    +4.72%
    36Kr·
    SZ
    300753
    +2.26%
    SZ
    301330
    +2.74%
    SH
    688626
    +4.72%

    The A-share brain-computer interface concept is actively defying the trend, with BIOTEST BIOTECH rising over 10%, and Meihao Medical, Sanbo, APON, and Xiangyu Medical following suit

    Wallstreetcn·
    SH
    688767
    -2.37%
    SZ
    300753
    +2.26%
    SZ
    301293
    +9.06%
    Wallstreetcn·
    SH
    688767
    -2.37%
    SZ
    300753
    +2.26%
    SZ
    301293
    +9.06%

    The three major A-share indices collectively closed higher, with the Shanghai Composite Index returning to 4,000 points

    36Kr·
    SH
    603598
    +1.73%
    SH
    688767
    -2.37%
    SH
    688068
    -0.20%
    36Kr·
    SH
    603598
    +1.73%
    SH
    688767
    -2.37%
    SH
    688068
    -0.20%

    Multiple A-share companies reveal progress and product updates in brain-computer interface technology

    Zhitong·
    SH
    688273
    -0.95%
    SH
    688767
    -2.37%
    SZ
    301330
    +2.74%
    Zhitong·
    SH
    688273
    -0.95%
    SH
    688767
    -2.37%
    SZ
    301330
    +2.74%
    © 2026 Longbridge｜Disclaimer